Huawei launches the Ascend P1 in the U.S. for $450 through Amazon






Despite its attempts to attract new customers with high-end phones, Huawei (002502) remains relatively unknown to U.S. consumers. The company is looking to change that and on Thursday announced the availability of the Ascend P1 smartphone. The Android-powered device is equipped with a 4.3-inch Super AMOLED display, a 1.5GHz dual-core processor, 1GB of RAM and an 8-megapixel rear camera. The handset is also one of the thinnest smartphones on the market, measuring in at 7.6 millimeters. BGR reviewed the Ascend P1 earlier this year and found it to be a decent smartphone. Huawei is offering the device carrier-unlocked through Amazon (AMZN) for $ 449.99. Read more for Huawei’s press release.


[More from BGR: Samsung confirms plan to begin inching away from Android]







Huawei’s Ascend P1 Launches in U.S.


[More from BGR: ‘iPhone 5S’ to reportedly launch by June with multiple color options and two different display sizes]


Super thin Huawei Ascend P1 comes with 1.5 GHz dual-core processor and Android 4.0 ICS OS


PLANO, Texas, Jan. 3, 2013 /PRNewswire/ — Huawei, a leading global information and communications technology (ICT) solutions provider, today announced an unlocked version of the Huawei Ascend P1 is available to U.S. consumers through Amazon.com. The Huawei Ascend P1 comes equipped with 1.5 GHz dual-core processor and is one of the fastest models in class, capable of handling 3D games effectively.


“The Ascend P1 is perfect for consumers looking to get the most out of their device,” said Michael Chuang, Executive Vice President of Huawei Device USA. “Whether it’s for playing games, streaming music and videos, or sharing multimedia in the home or workplace, the Ascend P1 offers unparalleled performance and a truly unique mobile experience.”


The Ascend P1 offers users a movie theatre-quality cinematic experience with its super AMOLED, 4.3 inch screen and 5.1 Dolby Surround Sound System. In addition, at only 7.69 mm thick, the Huawei Ascend P1 is one of the thinnest smartphones on the market. The 64.8 mm frame allows the Ascend P1 to sit comfortably in the user’s palm, giving them the ability to navigate all the phone’s features with a single hand.


The Huawei Ascend P1 is available online at Amazon.com for $ 449.99.



This article was originally published by BGR


Wireless News Headlines – Yahoo! News





Title Post: Huawei launches the Ascend P1 in the U.S. for $450 through Amazon
Url Post: http://www.news.fluser.com/huawei-launches-the-ascend-p1-in-the-u-s-for-450-through-amazon/
Link To Post : Huawei launches the Ascend P1 in the U.S. for $450 through Amazon
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Gabby Giffords to Meet Privately with Sandy Hook Families









01/04/2013 at 08:00 AM EST



Gabrielle Giffords, the former member of Congress from Arizona who was gunned down at a Tucson shopping center two years ago – and then courageously fought to recover from her injuries – will meet privately Friday with the families of the Sandy Hook school in Newtown, Conn.

The event will be held at a private home and is not open to the public.

Giffords, 42, sharing a Facebook post from her husband, former astronaut Mark Kelly, after the Dec. 14 school shootings, said that the time was now to begin a national dialogue on strengthening gun control. This week, she and Kelly met with New York City Mayor Michael Bloomberg, a staunch gun-control proponent, on the issue.

"As we mourn, we must sound a call for our leaders to stand up and do what is right," Kelly said.

"This time our response must consist of more than regret, sorrow, and condolence The children of Sandy Hook Elementary School and all victims of gun violence deserve leaders who have the courage to participate in a meaningful discussion about our gun laws – and how they can be reformed and better enforced to prevent gun violence and death in America. This can no longer wait."

Giffords left Congress in 2012 to focus on her recovery from a gunshot wound to the head. Jared Loughner, who killed six people during a shooting spree and wounded 15 others, was sentenced to life in prison last November.

Gabby Giffords to Meet Privately with Sandy Hook Families| Connecticut School Shootings, Gabrielle Giffords, Mark Kelly, Michael Bloomberg

Children from Sandy Hook Elementary School on their school bus, Jan. 3, 2013

Shannon Stapleton / Reuters / Landov

Read More..

Indian court to rule on generic drug industry


NEW DELHI (AP) — From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines.


The case — involving Swiss drug maker Novartis AG's cancer drug Glivec — pits aid groups that argue India plays a vital role as the pharmacy to the poor against drug companies that insist they need strong patents to make drug development profitable. A ruling by India's Supreme Court is expected in early 2013.


"The implications of this case reach far beyond India, and far beyond this particular cancer drug," said Leena Menghaney, from the aid group Doctors Without Borders. "Across the world, there is a heavy dependence on India to supply affordable versions of expensive patented medicines."


With no costs for developing new drugs or conducting expensive trials, India's $26 billion generics industry is able to sell medicine for as little as one-tenth the price of the companies that developed them, making India the second-largest source of medicines distributed by UNICEF in its global programs.


Indian pharmaceutical companies such as Cipla, Cadila Laboratories and Lupin have emerged over the past decade as major sources of generic cancer, malaria, tuberculosis and AIDS drugs for poor countries that can't afford to pay Western prices.


The 6-year-old case that just wrapped up in the Supreme Court revolves around a legal provision in India's 2005 patent law that is aimed at preventing companies from getting fresh patents for making only minor changes to existing medicines — a practice known as "evergreening."


Novartis' argued that a new version of Glivec — marketed in the U.S. as Gleevec — was a significant change from the earlier version because it was more easily absorbed by the body.


India's Patent Controller turned down the application, saying the change was an obvious development, and the new medicine was not sufficiently distinct from the earlier version to warrant a patent extension.


Patient advocacy groups hailed the decision as a blow to "evergreening."


But Western companies argued that India's generic manufacturers were cutting the incentive for major drug makers to invest in research and innovation if they were not going to be able to reap the exclusive profits that patents bring.


"This case is about safeguarding incentives for better medicines so that patients' needs will be met in the future," says Eric Althoff, a Novartis spokesman.


International drug companies have accused India of disregarding intellectual property rights, and have pushed for stronger patent protection that would weaken India's generics industry.


Earlier this year, an Indian manufacturer was allowed to produce a far cheaper version of the kidney and liver cancer treatment sorefinib, manufactured by Bayer Corp.


Bayer was selling the drug for about $5,600 a month. Natco, the Indian company, said its generic version would cost $175 a month, less than 1/30th as much. Natco was ordered to pay 6 percent in royalties to Bayer.


Novartis says the outcome of the new case will not affect the availability of generic versions of Glivec because it is covered by a grandfather clause in India's patent law. Only the more easily absorbed drug would be affected, Althoff said, adding that its own generic business, Sandoz, produces cheap versions of its drugs for millions across the globe.


Public health activists say the question goes beyond Glivec to whether drug companies should get special protection for minor tweaks to medicines that others could easily have uncovered.


"We're looking to the Supreme Court to tell Novartis it won't open the floodgates and allow abusive patenting practices," said Eldred Tellis, of the Sankalp Rehabilitation Centre, a private group working with HIV patients.


The court's decision is expected to be a landmark that will influence future drug accessibility and price across the developing world.


"We're already paying very high prices for some of the new drugs that are patented in India," said Petros Isaakidis, an epidemiologist with Doctors Without Borders. "If Novartis' wins, even older medicines could be subject to patenting again, and it will become much more difficult for us in future to provide medicines to our patients being treated for HIV, hepatitis and drug resistant TB."


Read More..

Stock futures drop after rally as investors book profit


NEW YORK (Reuters) - Wall Street was set for a slightly lower open on Thursday, as investors lock in gains after a rally Wednesday, which was spurred by a deal by U.S. lawmakers to avert a "fiscal cliff" of austerity measures that had been due to kick in this year.


Earlier losses in U.S. stock index futures Thursday were capped by better-than-expected data that showed U.S. private-sector employers added 215,000 jobs in December. That was well above economists' expectations for a gain of 133,000 jobs, according to a Reuters survey.


"The underlying economy has momentum, and the employment data confirms that. The political issues in Washington counter the momentum we're seeing in the economy, but you might see still equities grind higher today on this," said John Brady, managing director at R.J. O'Brien & Associates in Chicago.


A separate report showed the number of Americans filing new claims for unemployment benefits rose last week, but the data was too distorted by year-end holidays to offer a clear read of labor market conditions.


S&P 500 futures fell 2.3 points and were below fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures lost 20 points, while Nasdaq 100 futures dipped 1.00 point.


Wall Street began the new year Wednesday with a rally and their best performance in more than a year, sparked by a last-minute deal in Washington to avert a fiscal cliff of automatic massive tax hikes and spending cuts that, in the worst-case scenario, would have hurt the nation's economic growth.


The minutes of the Federal Reserve's policy meeting last month will be released at 2:00 p.m. EST. The minutes will give details on the discussions of the Federal Open Market Committee's December 11-12 meeting.


U.S. retailer Costco Wholesale Corp reported a better-than-expected 9 percent rise in December sales at stores open at least a year, mainly helped by an additional sales day in the reporting period. Costco shares were flat in premarket trading.


Gap Inc will buy women's fashion boutique Intermix Inc for $130 million to enter the luxury clothes market, the Wall Street Journal reported. The stock surged 4.9 percent to $32.90 in premarket trading.


Family Dollar Stores Inc reported a lower-than-expected quarterly profit as its emphasis on selling more everyday items like cigarettes and soft drinks put pressure on margins. The stock fell 8 percent to $58.89 in premarket trading.


Growth in China's increasingly important services sector accelerated in December at its fastest pace in four months, adding to signs of a modest year-end revival in the world's second-largest economy.


(Editing by Bernadette Baum)



Read More..

Depardieu, in Tax Fight, Gets Russian Citizenship







MOSCOW (AP) — Gerard Depardieu, the French actor who has waged a battle against a proposed super-tax on millionaires in his native country, has been granted Russian citizenship.




A brief announcement on the Kremlin website on Thursday revealed that President Vladimir Putin signed the citizenship grant following an application from the actor.


The former Oscar nominee and star of the movie "Green Card" has been vocal in his opposition to French President Francois Hollande's plans to raise the tax on earned income above €1 million ($1.33 million) to 75 percent from the current high of 41 percent. Russia has a flat 13-percent tax rate.


"I have never killed anyone, I don't think I've been unworthy, I've paid €145 million in taxes over 45 years," Depardieu wrote in an open letter in mid-December to Prime Minister Jean-Marc Ayrault, who had called the actor "pathetic."


"I will neither complain nor brag, but I refuse to be called 'pathetic,'" the 64-year-old actor wrote in his response.


A representative for the former Oscar nominee declined to say whether he had accepted the Russian offer, and refused all comment. Thursday was a holiday in Russia and officials from the Federal Tax Service and Federal Migration Service could not be reached for comment on whether the decision would require Depardieu to have a residence in Russia.


Depardieu said in his letter to Ayrault that he would surrender his passport and French social security card. In October, the mayor of a small Belgian border town announced that Depardieu had bought a house and set up legal residence there, a move that was slammed by the newly-elected Socialist government.


Najat Vallaud-Belkacem, the French government spokeswoman, didn't comment directly on Depardieu's tax fight, but drew a clear distinction between people who have personal or professional reasons to live abroad, and "French citizens who proclaim loudly and clearly that they they're exiling themselves for fiscal reasons."


She said Putin's offer "is an exclusive prerogative of the Russian chief of state."


Depardieu has had increasingly high-profile ties with Russia. Last October he visited the capital of Chechnya, Grozny, to celebrate the birthday of Chechen President Ramzan Kadyrov. And in 2011, he was in Russia's Arkhangelsk region to play the lead role in the film "Rasputin."


"You have to understand that Depardieu is a star in Russia," Vladimir Fedorovski, a Russian writer living in France, told the network Europe 1 on Thursday. "There are crowds around Depardieu. He's a symbol of France. He's a huge ambassador of French culture."


Though France's highest court struck down the two-year tax on Dec. 29, the government has promised to resubmit the law in a slightly different form soon. On Wednesday it estimated that the court decision to overturn the tax would cost it €210 million in 2013.


In an interview published Sunday, Depardieu told the Sunday Parisien that the court decision made no difference.


France's debt burden is around 90 percent of national income — not far off levels that have caused problems elsewhere in the 17-country eurozone.


Depardieu has made more than 150 films, among them the 1991 comedy "Green Card" about a man who enters into a marriage of convenience in order to get U.S. residency. Most famously, Depardieu was nominated for an Academy Award for his role as Cyrano de Bergerac in the 1990 film by the same name.


The Kremlin statement gave no information on why Putin made the citizenship grant, but the Russian president expressed sympathy with the actor in December, days after Depardieu reportedly said he was considering Russian citizenship.


"As we say, artists are easily offended and therefore I understand the feelings of Mr. Depardieu," Putin said.


Although France and Russia disagree sharply about how to resolve the civil war in Syria, the two countries have strong commercial relations. In 2011, Russia signed a contract worth more than €1 billion ($1.33 billion) Friday to buy two French warships — the largest military deal between a NATO country and Moscow.


Depardieu is well known in Russia, where he appears in an ad for Sovietsky Bank's credit card and is prominently featured on the bank's home page.


Depardieu is not the only high-profile Frenchman to object to the super-tax. Bernard Arnault — chief of the luxury goods and fashion giant LVMH and worth an estimated $41 billion — has also said he would leave for Belgium.


France's Civil Code says one must have another nationality in order to give up French citizenship because it is forbidden to be stateless. Thursday's decision by the Kremlin appears to fulfill that requirement.


____


Hinnant contributed from Paris. Silvie Corbet also contributed from Paris.


Read More..

Fake John le Carré Twitter Account Fakes J.K. Rowling’s Fake Twitter Death






We’ve seen “Cormac McCarthy” Tweet apocalyptic non sequiturs. “Philip Roth” promised us a bite-sized short story. Now a fake Twitter account for British spy novelist John le Carré is spreading bizarre death rumors about J.K. Rowling. After a few days of Tweeting harmless missives, the week-old handle @JLecarre dropped this would-be bombshell on its nearly 2,500 followers Wednesday morning: 



A terrible news. My publisher phones me announcing that J.K. Rowling dies by accident. Few minutes ago. No words!






— John le Carré (@JLecarre) January 2, 2013


OK, there are at least three dead-giveaways that this is a fake account. One: If J.K. Rowling had died, does anyone credibly think John le Carré would be the one breaking the news? Rowling and le Carré don’t even share a publisher—he’s with Penguin and she’s printed by Little, Brown and Company—making this story even more implausible. Two: As noted by le Carré’s literary agent Jonny Geller, the “L” in the author’s name shouldn’t be capitalized, as it is in the handle of this hoax account. Three: Phrases like “a terrible news” and “my publisher phones me” sound more like snippets from an ESL workbook than lines from an author praised for his chilly, controlled prose style. This could again be the work of Italian media troll Tommaso De Benedetti, who copped to creating a fake Philip Roth account recently. “Twitter works well for deaths,” he told The Guardian‘s Tom Kington, describing his M.O. for spreading misinformation about the deaths of public figures like Fidel Castro and Pedro Almodóvar. 


RELATED: Pippa’s Sales Figures Are Nothing to ‘Celebrate’; Salman Rushdie and John le Carré Call Truce


Too bad John le Carrè isn’t actually on Twitter, though. Imagine the flame wars he would get into with longtime adversary Salman Rushdie—who most certainly is on Twitter, and loves using it to throw literate shade. And too bad this isn’t the handiwork of someone with more imagination—someone like the unpublished Scottish novelist behind @cormaccmccarthy. Outed right here on The Atlantic Wire, Michael Crossan at least had the chops to fool Margaret Atwood and Twitter co-founder Jack Dorsey with dead-on spoofs of McCarthy’s writing: 


RELATED: Salman Rushdie’s Video Speech Gets Spiked; The World’s Priciest Books


f3b2d  51262e9e15782a25d8bfb4413c58deb7 541x163 Fake John le Carré Twitter Account Fakes J.K. Rowlings Fake Twitter Death


Social Media News Headlines – Yahoo! News




Read More..

Brandy: My Proposal Was a 'Spontaneous Thing'















01/03/2013 at 07:30 AM EST







Ryan Press and Brandy


Al Powers/Powers Imagery/Invision/AP


Brandy had no idea that her fiancé Ryan Press had plans to ask for her hand in marriage last week.

Then again, she doesn't think her beau knew he was going to, either.

"It was a spontaneous thing for my fiancé," she said before ringing in the New Year at LAVO Las Vegas "He just felt it."

The R&B singer and former Dancing with the Stars contestant first went public with her romance with music executive Ryan Press on New Year's Eve 2011, cuddling at a Las Vegas party. On Monday, they were back in Vegas, but this time she was sporting a glimmering ring.

Although Brandy, 33, told PEOPLE in March that she let Press know she'd "marry him with a bubble gum ring," the sparkler she did receive has impressed her.

"He worked really hard on the ring. I'm not a big diamond girl, but I really love this diamond he did," she said. "It just represents how he feels about me, and I'm really blessed to have someone like him in my life. He's truly a gift." 

Read More..

Flu? Malaria? Disease forecasters look to the sky


NEW YORK (AP) — Only a 10 percent chance of showers today, but a 70 percent chance of flu next month.


That's the kind of forecasting health scientists are trying to move toward, as they increasingly include weather data in their attempts to predict disease outbreaks.


In one recent study, two scientists reported they could predict — more than seven weeks in advance — when flu season was going to peak in New York City. Theirs was just the latest in a growing wave of computer models that factor in rainfall, temperature or other weather conditions to forecast disease.


Health officials are excited by this kind of work and the idea that it could be used to fine-tune vaccination campaigns or other disease prevention efforts.


At the same time, experts note that outbreaks are influenced as much, or more, by human behavior and other factors as by the weather. Some argue weather-based outbreak predictions still have a long way to go. And when government health officials warned in early December that flu season seemed to be off to an early start, they said there was no evidence it was driven by the weather.


This disease-forecasting concept is not new: Scientists have been working on mathematical models to predict outbreaks for decades and have long factored in the weather. They have known, for example, that temperature and rainfall affect the breeding of mosquitoes that carry malaria, West Nile virus and other dangerous diseases.


Recent improvements in weather-tracking have helped, including satellite technology and more sophisticated computer data processing.


As a result, "in the last five years or so, there's been quite an improvement and acceleration" in weather-focused disease modeling, said Ira Longini, a University of Florida biostatistician who's worked on outbreak prediction projects.


Some models have been labeled successes.


In the United States, researchers at Johns Hopkins University and the University of New Mexico tried to predict outbreaks of hantavirus in the late 1990s. They used rain and snow data and other information to study patterns of plant growth that attract rodents. People catch the disease from the droppings of infected rodents.


"We predicted what would happen later that year," said Gregory Glass, a Johns Hopkins researcher who worked on the project.


More recently, in east Africa, satellites have been used to predict rainfall by measuring sea-surface temperatures and cloud density. That's been used to generate "risk maps" for Rift Valley fever — a virus that spreads from animals to people and in severe cases can cause blindness or death. Researchers have said the system in some cases has given two to six weeks advance warning.


Last year, other researchers using satellite data in east Africa said they found that a small change in average temperature was a warning sign cholera cases would double within four months.


"We are getting very close to developing a viable forecasting system" against cholera that can help health officials in African countries ramp up emergency vaccinations and other efforts, said a statement by one of the authors, Rita Reyburn of the International Vaccine Institute in Seoul, South Korea.


Some diseases are hard to forecast, such as West Nile virus. Last year, the U.S. suffered one of its worst years since the virus arrived in 1999. There were more than 2,600 serious illnesses and nearly 240 deaths.


Officials said the mild winter, early spring and very hot summer helped spur mosquito breeding and the spread of the virus. But the danger wasn't spread uniformly. In Texas, the Dallas area was particularly hard-hit, while other places, including some with similar weather patterns and the same type of mosquitoes, were not as affected.


"Why Dallas, and not areas with similar ecological conditions? We don't really know," said Roger Nasci of the Centers for Disease Control and Prevention. He is chief of the CDC branch that tracks insect-borne viruses.


Some think flu lends itself to outbreak forecasting — there's already a predictability to the annual winter flu season. But that's been tricky, too.


Seasonal flu reports come from doctors' offices, but those show the disease when it's already spreading. Some researchers have studied tweets on Twitter and searches on Google, but their work has offered a jump of only a week or two on traditional methods.


In the study of New York City flu cases published last month in the Proceedings of the National Academy of Sciences, the authors said they could forecast, by up to seven weeks, the peak of flu season.


They designed a model based on weather and flu data from past years, 2003-09. In part, their design was based on earlier studies that found flu virus spreads better when the air is dry and turns colder. They made calculations based on humidity readings and on Google Flu Trends, which tracks how many people are searching each day for information on flu-related topics (often because they're beginning to feel ill).


Using that model, they hope to try real-time predictions as early as next year, said Jeffrey Shaman of Columbia University, who led the work.


"It's certainly exciting," said Lyn Finelli, the CDC's flu surveillance chief. She said the CDC supports Shaman's work, but agency officials are eager to see follow-up studies showing the model can predict flu trends in places different from New York, like Miami.


Despite the optimism by some, Dr. Edward Ryan, a Harvard University professor of immunology and infectious diseases, is cautious about weather-based prediction models. "I'm not sure any of them are ready for prime time," he said.


Read More..

Wall Street set for rally in wake of fiscal pact

NEW YORK (Reuters) - Wall Street was set to rally on the first trading day of 2013, after lawmakers agreed a deal to avoid massive tax hikes and spending cuts that had threatened to hurt economic growth.


The gains would come after stocks ended 2012 with their strongest day in more than a month, which put the S&P 500 up 13.4 percent for the year, after a flat performance in 2011.


Late on Tuesday, the House of Representatives voted for a bill that will raise taxes on wealthy individuals and families and preserve certain benefits.


The vote averted immediate austerity measures, like tax hikes for almost all U.S. households, although it didn't resolve other political showdowns on the budget due in coming months. Spending cuts of $109 billion in military and domestic programs were only delayed for two months.


"We are looking at a sharply higher open on Wall Street," said Peter Cardillo, chief market analyst for Rockwell Global Capital in New York. "The deal certainly brightens the prospects for economic growth, and traditionally speaking, the first week of the year generally sets the stage for the rest of the year for equities - so this is positive."


"There is a lot of euphoria out there and I expect, for the next day or two, the market will continue on the upside. We will see money re-entering the market," Cardillo said.


S&P 500 futures rose 26.8 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures gained 203 points, and Nasdaq 100 futures added 57.25 points.


The long-awaited U.S. fiscal deal lifted global shares at the start of the new year. The pan-European FTSEurofirst 300 <.fteu3> was up 1.6 percent and the MSCI world index <.miwd00000pus> rose 0.8 percent. The MSCI Asia Pacific ex-Japan index of stocks <.miapj0000pus> surged 2.1 percent. Japanese markets were closed Wednesday for a holiday.


On the macroeconomic front, the Institute for Supply Management's manufacturing sector survey will be released at 10:00 a.m. ET (1500 GMT). A Reuters survey forecasts the main index at 50.3 compared with 49.5 in November.


Also at 10:00 a.m., November construction spending data will be released. A Reuters survey forecasts a 0.6 percent rise in construction spending, versus 1.4 percent in the prior month.


On the last day of trading in 2012, the Dow Jones industrial average <.dji> gained 166.03 points, or 1.28 percent, to close at 13,104.14. The Standard & Poor's 500 Index <.spx> gained 23.76 points, or 1.69 percent, to finish at 1,426.19. The Nasdaq Composite Index <.ixic> gained 59.20 points, or 2.00 percent, to close at 3,019.51.


In 2012, the Dow advanced 7.3 percent, while the Nasdaq climbed 15.9 percent.


(Editing by Bernadette Baum)



Read More..

IHT Rendezvous: Hoping to End Decades-long Kurdish Conflict, Turkey Calls on Archenemy

LONDON — Turkish intelligence agents have been making the short hop from Istanbul across the Sea of Marmara to the prison Island of Imrali in recent weeks for talks with a jailed Kurdish separatist leader who was once Turkey’s most wanted man.

Abdullah Ocalan, founder of the Kurdistan Workers’ Party, the P.K.K., has been languishing on Imrali since he was captured in Nairobi, Kenya in 1999 while on the run. He is serving a life term after a death sentence was commuted.

Now the Turkish government wants his help to end a resurgent war with P.K.K. rebels that has claimed around 900 lives in the last year and a half.

Recep Tayyip Erdogan, the Turkish prime minister, revealed the dialog last week when he told state-run TRT television, “I cannot hold such meetings myself as a politician but the state has agents and they do.”

In an acknowledgement that the latest escalation in a three-decade battle against the Kurdish insurgents was probably unwinnable, Yalcin Akdogan, a senior adviser to Mr. Erdogan, said this week that the talks were aimed at persuading the P.K.K. to disarm.

“The government supports any dialog to this end that could result in a halt to violence,” Mr. Akdogan said in a television interview. “You cannot get results and abolish an organization only with armed struggle.”

The strategy of seeking a deal with the P.K.K. has implications for Turkey’s policy in neighboring Syria, where Kurdish militants linked to the organization have taken over territory vacated by retreating government forces.

Turkey “fears that an autonomous Kurdish region in Syria would become a haven for Kurdish militants to carry out cross-border attacks in the Kurdish areas in southeastern Turkey,” my colleague Tim Arango wrote recently in a report from the border region.

Tensions over Syria and the Kurdish issue have also led to a souring of Turkey’s relations with Iran and the Iraqi government in Baghdad, as Ankara struggled to cope with the aftermath of the so-called Arab Spring.

There is a question mark over how much authority the jailed Mr. Ocalan has over the P.K.K. leadership, which is based in the Qandil mountains in the Kurdish region of northern Iraq. “He remains a figure of symbolic importance,” Mr. Akdogan said of the P.K.K. founder. “But we still have to wait and see how Qandil will react.”

Mr. Ocalan’s capture in 1999 was a cause of national celebration among Turks after the worst years of a war that has cost 40,000 lives, including those of Turkish and Kurdish civilians. The P.K.K. is regarded as a terrorist organization by, among others, the United States and the European Union.

However, the Turkish authorities have not shrunk from dealing with Mr. Ocalan in the past to intervene in Kurdish matters.

In November, he saved the authorities from an escalating crisis that threatened to worsen tensions with the Kurds by calling on hundreds of his imprisoned supporters to halt a two-month hunger strike. The protesters had been demanding an end to Mr. Ocalan’s isolation and improved rights for Turkey’s Kurdish minority, which makes up 20 percent of its population.

Andrew Finkel wrote in the IHT’s Global Views opinion section that the intervention signaled the resumption of Mr. Ocalan’s career.

Mr. Ocalan is now reportedly demanding direct contact with the P.K.K.’s leadership and improved prison conditions as the price for his cooperation in persuading the militants to lay down their arms.

Some observers have cast doubt on the government’s strategy of dealing with Mr. Ocalan while failing to carry out reforms in favor of the country’s Kurdish minority.

David Rohde wrote in a Rendezvous article at the weekend that more than 10,000 Kurds were imprisoned in Turkey on various terrorism charges.

According to Hugh Pope, project director of the International Crisis Group in Turkey, the government of Mr. Erdogan is putting the cart before the horse. “They need to find a Kurdish settlement first before cutting a deal with the P.K.K.,” he told Rendezvous from Istanbul.

That would include instituting promised reforms that would give equality to Turkey’s Kurdish citizens, including the right to a Kurdish-language education.

“The P.K.K. wants to do a deal and obviously Ocalan is desperate to get out of jail,” Mr. Pope said. “He may be an essential ingredient but he’s not the magic key.”

Read More..